Dexcom is using the soon-to-be released Apple Watch for its wearable glucose monitor. The Apple Watch showing a heartbeat. (Image courtesy of Apple) Nancy Crotti In the highly competitive, continuous-glucose-monitoring device ...
Tags: Apple Tech, Diabetes Tech
It seems that a fight is looming over a seat on Echo Therapeutics Inc.'s board of directors. The company's largest shareholder, an investor group led by Platinum Management (NY), LLC, which owns approximately 19.9% of Echo's common ...
February 3, 2014 -- The U.S. Food and Drug Administration today approved the expanded use of the Dexcom G4 Platinum Continuous Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood ...
Tags: FDA
A so-called implantable insulin delivery device could one day free people with type 1 diabetes from the need for multiple daily injections, scientists say. "Diabetes is a difficult-to-treat condition, and yet keeping in very good balance ...
Echo Therapeutics’ Symphony CGM system has won Medical Devices Business Review’s Medical Device Innovation Award. Echo's device was selected from four nominations shortlisted for the award. Symphony CGM system is a ...
Tags: Medical Device, Medicine
Echo Therapeutics, a medical device company developing its Symphony CGM system as a non-invasive, wireless continuous glucose monitoring system, has entered into a strategic collaboration agreement with Medical Technologies Innovation Asia ...
Echo Therapeutics, a medical device company, has reported positive results from its clinical trial of the Symphony CGM wireless continuous glucose monitoring system in surgical patients in hospital critical care units. Echo Therapeutics ...
Bayer HealthCare has announced that the US Food and Drug Administration (FDA) has cleared its CONTOUR next link blood glucose monitoring (BGM) system as a component of Medtronic's new MiniMed 530G with Enlite, a breakthrough diabetes ...
Tags: Bayer HealthCare, Medicine
The US Food and Drug Administration (FDA) has cleared Dexcom's new continuous glucose monitoring (CGM) system. The G4 PLATINUM system comprises a tiny sensor which is inserted by the user under the skin on the abdomen and a transmitter ...
Tags: Dexcom, continuous glucose monitoring system, G4 PLATINUM system
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Echo Therapeutics' claimed application for its Prelude SkinPrep system and Symphony tCGM system. The claimed Patent Application No. 10/792,862 entitled ...
Tags: USPTO, NOA, application, notice of allowance, Prelude SkinPrep system
Echo Therapeutics has reported positive results from a clinical study of its Symphony tCGM system, designed to provide real-time blood glucose data continuously and cost-effectively. Designed as a non-invasive, wireless, transdermal ...
Tags: Echo Therapeutics, clinical study, Symphony tCGM system, CG-EGA